| PRKDC |
PRKDC, HYRC, HYRC1: DNA-dependent protein kinase catalytic subunit |
EIF2B1 |
EIF2B1, EIF2BA: Translation initiation factor eIF-2B subunit alpha |
1.172 |
Evidence |
|
| B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
LOC162427 |
FAM134C: Protein FAM134C |
1.172 |
Evidence |
|
| SUMO3 |
SUMO3, SMT3A, SMT3H1: Small ubiquitin-related modifier 3 precursor |
SERBP1 |
IPI00412714 |
1.172 |
Evidence |
|
| ADAR |
ADAR, ADAR1, DSRAD, G1P1, IFI4: Double-stranded RNA-specific adenosine deaminase |
BECN1 |
BECN1, GT197: Beclin-1 |
1.172 |
Evidence |
|
| MFAP4 |
MFAP4: Microfibril-associated glycoprotein 4 precursor |
MUC1 |
IPI00607569 |
1.172 |
Evidence |
|
| CSE1L |
CSE1L, CAS, XPO2: Exportin-2 |
FLJ20297 |
IPI00301683 |
1.172 |
Evidence |
|
| SLC6A8 |
SLC6A8: Sodium- and chloride-dependent creatine transporter 1 |
UBE2H |
UBE2H: Ubiquitin-conjugating enzyme E2 H |
1.172 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
FXYD5 |
FXYD5, DYSAD, HSPC113, IWU1, UNQ2561/PRO6241: FXYD domain-containing ion transpo |
1.172 |
Evidence |
|
| MSH2 |
MSH2: DNA mismatch repair protein Msh2 |
PTMA |
IPI00015550 |
1.172 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
LSP1 |
|
1.172 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
FXYD5 |
FXYD5, DYSAD, HSPC113, IWU1, UNQ2561/PRO6241: FXYD domain-containing ion transpo |
1.172 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
FXYD5 |
FXYD5, DYSAD, HSPC113, IWU1, UNQ2561/PRO6241: FXYD domain-containing ion transpo |
1.172 |
Evidence |
|
| TCEA1 |
TCEA1, GTF2S, TFIIS: Transcription elongation factor A protein 1 |
LSM7 |
LSM7: U6 snRNA-associated Sm-like protein LSm7 |
1.172 |
Evidence |
|
| ITGAX |
ITGAX, CD11C: Integrin alpha-X precursor |
CKLF |
IPI00008841 |
1.172 |
Evidence |
|
| SNRPB2 |
SNRPB2: U2 small nuclear ribonucleoprotein B'' |
PMS2L3 |
PMS2L3: Uncharacterized protein PMS2L3 |
1.172 |
Evidence |
|
| CD74 |
IPI00217775 |
HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
1.172 |
Evidence |
|
| APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
LR8 |
TMEM176B, LR8: Transmembrane protein 176B |
1.172 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
DAK |
DAK: Dihydroxyacetone kinase |
1.172 |
Evidence |
|
| PRPF6 |
PRPF6, C20orf14: Pre-mRNA-processing factor 6 |
HSPC142 |
C19orf62, HSPC142: Uncharacterized protein C19orf62 |
1.172 |
Evidence |
|
| PBK1 |
RSL1D1, CATX11, L12, CSIG, PBK1: Ribosomal L1 domain-containing protein 1 |
UQCRC2 |
UQCRC2: Ubiquinol-cytochrome-c reductase complex core protein 2, mitochondrial p |
1.172 |
Evidence |
|
| EIF4EBP3 |
EIF4EBP3: Eukaryotic translation initiation factor 4E-binding protein 3 |
EIF4G2 |
EIF4G2, DAP5, OK/SW-cl.75: Eukaryotic translation initiation factor 4 gamma 2 |
1.172 |
Evidence |
|
| ORC5L |
ORC5L: Origin recognition complex subunit 5 |
DBF4 |
DBF4, ASK: Protein DBF4 homolog |
1.172 |
Evidence |
|
| ARPC3 |
ARPC3, ARC21: Actin-related protein 2/3 complex subunit 3 |
MICAL1 |
MICAL1, MICAL, NICAL: NEDD9-interacting protein with calponin homology and LIM d |
1.172 |
Evidence |
|
| HMGN4 |
HMGN4, HMG17L3, NHC: High mobility group nucleosome-binding domain-containing pr |
RPS7 |
RPS7: 40S ribosomal protein S7 |
1.172 |
Evidence |
|
| HMGN4 |
HMGN4, HMG17L3, NHC: High mobility group nucleosome-binding domain-containing pr |
ARPC3 |
ARPC3, ARC21: Actin-related protein 2/3 complex subunit 3 |
1.172 |
Evidence |
|